Men could be given a quick all-clear or cancer diagnosis within 24 hours under a one-day scheme that uses AI to interpret MRI ...

LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...

NEW HAVEN, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of therapies called RIPTAC™ Therapeutics, today announced that ...

Biden’s personal office revealed in May that he had been diagnosed with an “aggressive form” of prostate cancer that had ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

NHS England will pilot AI-assisted, same-day prostate cancer diagnostics at Leeds, aiming to cut waits by up to a month and ...

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it - It comes as concerns ...

Find out how the NHS is using AI to diagnose prostate cancer faster, potentially improving outcomes for thousands of men ...